Ko te Xanthelasma he putunga kowhai kowhai o te cholesterol i raro i te kiri. I te nuinga o te wa ka puta ki runga, ki nga kamo ranei. Ahakoa karekau he kino ki te kiri, he mamae ranei, ka kino pea enei tipu iti ka taea te tango. Kei te tipu haere nga taunakitanga mo te hononga i waenga xanthelasma me nga taumata lipoprotein iti-kiato toto me te nui o te tupono o te atherosclerosis.
○ Maimoatanga Ka taea te rongoa i nga whiu iti ki te laser, engari he mea tino noa te hokinga mai.
Ko te Xanthelasma palpebrarum he ahua ka puta he putunga kowhai, he papanga ranei kei roto i nga kokonga o roto o nga kamo. He pai, a, kaore e pa ki te hauora. Tata ki te haurua o nga pakeke whai xanthelasma he rereke nga taumata lipid. I roto i te hunga rangatahi, ina koa nga tamariki, ki te kite i te xanthelasma ka tohu pea he mate lipid tuku iho. Ko te maimoatanga mo te xanthelasma i te nuinga o te waa mo nga take whakapaipai, na te mea kaore e hiahiatia ana mo nga take rongoa. Xanthelasma palpebrarum is primarily characterized by soft, lipid-rich deposits, especially cholesterol, manifesting as semisolid, yellowish papules or plaques. These deposits are typically found on the inner aspect of the eyes and are most commonly located along the corners of the upper and lower eyelids. Xanthelasma palpebrarum is a benign lesion and does not pose significant health risks. Approximately 50% of adult patients with xanthelasma have abnormal lipid levels. In younger individuals, particularly children, the presence of xanthelasma should prompt consideration of an underlying inherited dyslipidemia. Although xanthelasma treatment is typically not medically necessary, some patients may seek therapy for cosmetic reasons.
○ Maimoatanga
Ka taea te rongoa i nga whiu iti ki te laser, engari he mea tino noa te hokinga mai.